Cite
HARVARD Citation
Kashefi, S. et al. (2019). A randomized, controlled, phase II clinical trial of β‐D‐mannuronic acid (M2000) in pre‐surgical breast cancer patients at early stage (T1‐T2). Clinical and experimental pharmacology and physiology. pp. 527-532. [Online].